Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Noonan Syndrome × nazartinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1 Gastrointestinal 1 Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 2 Squamous Cell Carcinoma of Head and Neck 1 Noonan Syndrome 1 Melanoma 1 Lung Neoplasms 1 Esophageal Squamous Cell Carcinoma 1

Interventions

nazartinib 1 Lovastatin 1 Lamotrigine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03114319 2025-08-28

Dose Finding Study of TNO155 in Adult Patients With Advanced Solid Tumors

Novartis

Phase 1 Terminated

DermatologicGastrointestinalHead & Neck

Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Melanoma, Noonan Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡